Status:
COMPLETED
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cognitive/Functional Effects
Recurrent Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This clinical trial studies vascular and cognitive assessments in patients with breast cancer undergoing chemotherapy after surgery. Learning about vascular and cognitive function may help plan treatm...
Detailed Description
PRIMARY OBJECTIVES: I. To assess the feasibility of enrolling women who are receiving adjuvant chemotherapy for breast cancer to a clinical trial with assessments of vascular function and cognition b...
Eligibility Criteria
Inclusion
- Patients must have histologically or cytologically confirmed non-metastatic breast cancer; stages 1-3 are acceptable
- Patients must be candidates for either neoadjuvant or adjuvant chemotherapy for breast cancer
- Ability to understand and the willingness to sign a written informed consent document
Exclusion
- Patients who have had prior systemic chemotherapy are not eligible for the study
- Patients who are scheduled to receive trastuzumab and/or bevacizumab are not eligible
- Patients who are on dialysis
- Women who are pregnant are not eligible due to unknown risks and potential harm to the unborn fetus
- Patients with metastatic breast cancer are not eligible
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01483196
Start Date
January 1 2012
End Date
May 1 2014
Last Update
July 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157